Aria Ilyad Ahmad is a PhD candidate in global governance, specializing in global health governance. His broad research interests include how emerging global health challenges are framed as well as pharmaceutical policy, with a particular focus on the role of formal and informal institutions in the governance of drug quality. Aria’s doctoral research examines the disbanding of the World Health Organization’s International Medical Products Anti-Counterfeiting Taskforce. He is currently based in Geneva at the WHO as a 2014 Global Health Fellow in the Duke Global Policy and Governance Program.
Aria was also the inaugural Médecins Sans Frontières Access Fellow in India, a past TEDMED Scholar, and has testified before the Canadian Senate on Canada’s Access to Medicines Regime. In addition to serving on the Board of Directors of Universities Allied for Essential Medicines and the Global Steering Committee of the Young Professionals Chronic Disease Network, Aria has worked on public health emergency preparedness at Public Health Ontario. Aria received his MSc in international pharmaceutical policy from the University of Toronto, where he held affiliations with the Global Health Diplomacy Program, the Initiative for Drug Equity and Access and the Graduate Student Alliance for Global Health.